Can the 8 Worst-Performing Dow Jones Stocks in 2024 Beat the S&P 500 in 2025?
Eight of the 30 Dow components lost value in 2024. Here's a quick look at each company, to help you determine which dividend ...
Medical Design and Outsourcing2h
NAMSA acquires WuXi’s U.S. manufacturing facilities
NAMSA recently announced plans to acquire WuXi AppTec’s medical device testing operations in the U.S. As part of the ...
FiercePharma8h
Leo bags EU rights to Junshi’s Loqtorzi, putting marketing muscle behind PD-1 launch
Leo Pharma has stepped up to commercialize toripalimab in Europe, inking a deal with Shanghai Junshi Biosciences to secure ...
Why Summit Therapeutics Stock Is Jumping Today
Shares of Summit Therapeutics (NASDAQ: SMMT) had jumped 14.3% at 11:31 a.m. ET on Tuesday. The nice gain came after reports ...
Top 15 Dividend Stocks to Buy Now
Verizon is a telecommunications powerhouse renowned for its consistent dividend payments. As of January 21, 2025, its stock ...
OPKO Health, Inc. (OPK) Stock: An Under $5 Gem with Biggest Upside Potential
We recently compiled a list of the 12 Stocks Under $5 With Biggest Upside Potential. In this article, we are going to take a ...
Merck & Co. Inc. stock underperforms Tuesday when compared to competitors
Shares of Merck & Co. Inc. MRK slid 1.72% to $96.24 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.88% to 6,049.24 and ...
Merck price target lowered to $113 from $123 at Morgan Stanley
Morgan Stanley analyst Terence Flynn lowered the firm’s price target on Merck (MRK) to $113 from $123 and keeps an Equal Weight rating on the ...